AstraZeneca Dividends and Buybacks
Dividend criteria checks 4/6
AstraZeneca is a dividend paying company with a current yield of 2.36% that is well covered by earnings.
Key information
2.4%
Dividend yield
0.02%
Buyback Yield
| Total Shareholder Yield | 2.4% |
| Future Dividend Yield | 2.7% |
| Dividend Growth | -8.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$3.011 |
| Payout ratio | 71% |
Recent dividend and buyback updates
No updates
Recent updates
AstraZeneca: Strong Growth Potential And Market Volatility Offer Opportunity
Nov 13AstraZeneca: Contrarian Buy After The China Challenge (Rating Upgrade)
Nov 07AstraZeneca: Buy This Big Pharma Stock At A Discount Now
Sep 24AstraZeneca: Dato-DXd Should Still Be Approved In Q4 Despite Underwhelming Data
Sep 12Stability and Growth of Payments
Fetching dividends data
Stable Dividend: AZN's dividend payments have been volatile in the past 10 years.
Growing Dividend: AZN's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| AstraZeneca Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (AZN) | 2.4% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.3% |
| Industry Average (Pharmaceuticals) | 2.5% |
| Analyst forecast (AZN) (up to 3 years) | 2.7% |
Notable Dividend: AZN's dividend (2.36%) is higher than the bottom 25% of dividend payers in the US market (1.39%).
High Dividend: AZN's dividend (2.36%) is low compared to the top 25% of dividend payers in the US market (4.32%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (70.9%), AZN's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (66.5%), AZN's dividend payments are covered by cash flows.